Department of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON.
Faculty of Medicine, University of Ottawa, Ottawa, ON.
Can J Ophthalmol. 2023 Aug;58(4):346-355. doi: 10.1016/j.jcjo.2022.02.010. Epub 2022 Mar 16.
This study aims to synthesize data quantifying the prevalence and severity of common psychological conditions in patients with glaucoma.
Systematic review and meta-analysis.
Databases including Ovid MEDLINE, CINAHL, EMBASE, PsycINFO, Cochrane Library, Web of Science, Open Grey, and ProQuest Theses and dissertations were searched. Two reviewers independently assessed and screened all studies, followed by quality assessment of included studies using the modified Downs and Black checklist. Data were pooled using fixed-effect and random-effects models.
Of 2067 studies identified by the search strategy, 57 passed full-text screening, and 45 studies (4 995 538 subjects) were eligible for analysis. Overall, the prevalence of depression (effect size [ES] = 0.19, 95% CI 0.16-0.23; n = 31), anxiety (ES = 0.25, 95% CI 0.21-0.30; n = 18), and sleep disorders (ES = 0.47, 95% CI 0.26-0.68; n = 7) were high in patients with glaucoma. Similarly, symptomatic measurements of depression (standardized mean difference [SMD] = 0.46, 95% CI 0.19-0.73), anxiety (SMD = 0.44, 95% CI 0.08-0.81), and sleep quality (SMD = 0.72, 95% CI 0.22-1.21) were significant in glaucoma patients.
A higher prevalence and severity of depression, anxiety, and sleep disorders was experienced in patients with glaucoma compared with patients without glaucoma. Caregivers as well as health care providers may need to be aware of unique psychological and social stressors placed on glaucoma patients.
本研究旨在综合量化青光眼患者常见心理状况的患病率和严重程度的数据。
系统评价和荟萃分析。
检索了 Ovid MEDLINE、CINAHL、EMBASE、PsycINFO、Cochrane 图书馆、Web of Science、Open Grey 和 ProQuest 论文和学位论文数据库。两位审查员独立评估和筛选了所有研究,并使用改良的 Downs 和 Black 清单对纳入研究进行了质量评估。使用固定效应和随机效应模型汇总数据。
通过搜索策略确定的 2067 项研究中,有 57 项通过全文筛选,45 项研究(3199538 名受试者)符合分析条件。总体而言,青光眼患者的抑郁患病率(效应量[ES] = 0.19,95%CI 0.16-0.23;n = 31)、焦虑(ES = 0.25,95%CI 0.21-0.30;n = 18)和睡眠障碍(ES = 0.47,95%CI 0.26-0.68;n = 7)较高。同样,青光眼患者的抑郁症状测量(标准化均数差[SMD] = 0.46,95%CI 0.19-0.73)、焦虑(SMD = 0.44,95%CI 0.08-0.81)和睡眠质量(SMD = 0.72,95%CI 0.22-1.21)也有显著差异。
与无青光眼患者相比,青光眼患者经历了更高的抑郁、焦虑和睡眠障碍的患病率和严重程度。护理人员和医疗保健提供者可能需要意识到青光眼患者面临的独特的心理和社会压力源。